 |
| 首页 > 美迪医讯 > Research Report on Chinese Antihypertensive Drugs Market |
Research Report on Chinese Antihypertensive Drugs Market 【 2008-08-12 发布 】 美迪医讯
Research Report on Chinese Antihypertensive Drugs MarketPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,100
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
1 Summary
2 Categories and market overview
2.1 CCB (calcium-channel blocker)
2.2 ACEI （angiotensin-converting enzyme inhibitor）
2.3 ARBs (angiotensin Ⅱ receptor blocker)
2.4 β-blocker
2.5 α-blocker
2.6 Diuretic
2.7 Others
3 Sales analysis of the past 4 years
3.1 Market scale and growth trend
3.2 Market share and change trend
3.2.1 Sales shares of different products of Antihypertensive Drugs
3.2.2 Sales shares of different products of CCB
3.2.3 Sales shares of different products of ACEI
3.2.4 Sales shares of different products of ARBs
3.2.5 Sales shares of different products of β-blocker
3.2.6 Sales shares of different products of α-blocker
3.2.7 Sales shares of different products of diuretic
3.2.8 Others
3.3 Change about sales rank of key brands
4 Market analysis of last year
4.1 Sales shares of different products
4.2 Sales shares of different brands
4.3 Key products and competitive enterprises of CCB
Amlodipine
Nifedipine
Felodipine
Nimodipine
levamlodipine
Nitrendipine
Nisoldipine
Others
4.4 Key products and competitive enterprises of ACEI
Benazepril
Enalapril
Captopril
Lysinopril
Ramipril
Compound Captopril
Others
4.5 Key products and competitive enterprises of ARBs
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan
Coumpand preparation
4.6 Key products and competitive enterprises of β-blocker
4.7 Key products and competitive enterprises of α-blocker
4.8 Key products and competitive enterprises of α-blocker
4.9 Key products and competitive enterprises of Diuretic
5 Sales analysi of key cities
6 Research and development in China
6.1 Lsit of Domestic marketd products and import procucts
6.2 Status of application and approval for Blood Thinning Drugs
本文关键字:
收藏本文到:
          .text:''):(d.getSelection?d.getSelection():'');void(keyit=window.open('http://my.poco.cn/fav/storeIt.php?t='+escape(d.title)+'&u='+escape(d.location.href)+'&c='+escape(t)+'&img=http://www.h-strong.com/blog/logo.gif','keyit','scrollbars=no,width=475,height=575,status=no,resizable=yes'));keyit.focus(); "添加到POCO网摘"){kind=logo}  《美迪医讯》欢迎您参与新闻投稿，业务咨询： 美迪医疗网业务咨询《上海医疗器械批发》产品推荐
|
| 合作支持：中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会 |
| 刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图 |
| 把美迪网放进收藏夹 把美迪医疗网介绍给我的朋友 给美迪医疗网留言
美迪医疗网广告业务联系：021-51601230 产品咨询业务联系：021-51601230 传真：021-56532303 
美迪医疗网业务咨询
互联网药品信息服务许可证：(沪)-经营性-2009-0003 中华人民共和国电信与信息服务业务经营许可证：(沪)B2-20090029  沪ICP备14001091号-8  公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号 营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081 |
